The data indicates that malignant neoplasms mortality in Japan is projected to increase from 366.6 per 100,000 men in 2024 to 372.6 per 100,000 men in 2028. Compared to the actual figures for 2023, there is an upward trend in the mortality rate. The year-on-year percentage variation shows a consistent rise of approximately 0.41% from 2024 to 2028. Over the last two years preceding 2024, the trend also indicates a steady increase. The compound annual growth rate (CAGR) reflecting the average annual growth over the last five years is set at 0.41%, underlining a gradual annual rise in malignant neoplasms mortality.
Future trends to watch for include advancements in medical technology and treatment protocols, which may impact these projections positively. Additionally, lifestyle changes and government health policies aimed at cancer prevention and early detection could also alter these trends in the upcoming years.
